Prelude Capital Management’s Stoke Therapeutics STOK Stock Holding History

Prelude Capital Management’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$326K	Sell
2024 Q3	$613K	Buy